참고문헌
- Abel, J. and Haarmann-Stemmann, T. (2010). An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol. Chem. 391, 1235-1248. https://doi.org/10.1515/bc.2010.128
- Assi, R., Kantarjian, H.M., Kadia, T.M., Pemmaraju, N., Jabbour, E., Jain, N., Daver, N., Estrov, Z., Uehara, T., Owa, T., et al. (2018). Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome. Cancer 124, 2758-2765. https://doi.org/10.1002/cncr.31398
- Bosu, D.R. and Kipreos, E.T. (2008). Cullin-RING ubiquitin ligases: global regulation and activation cycles. Cell Div. 3, 7. https://doi.org/10.1186/1747-1028-3-7
- Bussiere, D.E., Xie, L., Srinivas, H., Shu, W., Burke, A., Be, C., Zhao, J., Godbole, A., King, D., Karki, R.G., et al. (2020). Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex. Nat. Chem. Biol. 16, 15-23. https://doi.org/10.1038/s41589-019-0411-6
- Du, X., Volkov, O.A., Czerwinski, R.M., Tan, H., Huerta, C., Morton, E.R., Rizzi, J.P., Wehn, P.M., Xu, R., Nijhawan, D., et al. (2019). Structural basis and kinetic pathway of RBM39 recruitment to DCAF15 by a sulfonamide molecular glue E7820. Structure 27, 1625-1633.e3. https://doi.org/10.1016/j.str.2019.10.005
- Faust, T.B., Yoon, H., Nowak, R.P., Donovan, K.A., Li, Z., Cai, Q., Eleuteri, N.A., Zhang, T., Gray, N.S., and Fischer, E.S. (2020). Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15. Nat. Chem. Biol. 16, 7-14. https://doi.org/10.1038/s41589-019-0378-3
- Gradin, K., McGuire, J., Wenger, R.H., Kvietikova, I., fhitelaw, M.L., Toftgard, R., Tora, L., Gassmann, M., and Poellinger, L. (1996). Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell. Biol. 16, 5221-5231. https://doi.org/10.1128/MCB.16.10.5221
- Haddad, R.I., Weinstein, L.J., Wieczorek, T.J., Bhattacharya, N., Raftopoulos, H., Oster, M.W., Zhang, X., Latham, V.M., Jr., Costello, R., Faucher, J., et al. (2004). A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor. Clin. Cancer Res. 10, 4680-4687. https://doi.org/10.1158/1078-0432.CCR-04-0229
- Han, T., Goralski, M., Gaskill, N., Capota, E., Kim, J., Ting, T.C., Xie, Y., Williams, N.S., and Nijhawan, D. (2017). Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science 356, eaal3755. https://doi.org/10.1126/science.aal3755
- Hannah, J. and Zhou, P. (2015). Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B. Gene 573, 33-45. https://doi.org/10.1016/j.gene.2015.08.064
- Hsiehchen, D., Goralski, M., Kim, J., Xie, Y., and Nijhawan, D. (2020). Biomarkers for RBM39 degradation in acute myeloid leukemia. Leukemia 34, 1924-1928. https://doi.org/10.1038/s41375-020-0729-9
- Hughes, S.J. and Ciulli, A. (2017). Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders. Essays Biochem. 61, 505-516. https://doi.org/10.1042/EBC20170041
- Huttlin, E.L., Bruckner, R.J., Paulo, J.A., Cannon, J.R., Ting, L., Baltier, K., Colby, G., Gebreab, F., Gygi, M.P., Parzen, H., et al. (2017). Architecture of the human interactome defines protein communities and disease networks. Nature 545, 505-509. https://doi.org/10.1038/nature22366
- Huttlin, E.L., Ting, L., Bruckner, R.J., Gebreab, F., Gygi, M.P., Szpyt, J., Tam, S., Zarraga, G., Colby, G., Baltier, K., et al. (2015). The BioPlex network: a systematic exploration of the human interactome. Cell 162, 425-440. https://doi.org/10.1016/j.cell.2015.06.043
- Jung, D.J., Na, S.Y., Na, D.S., and Lee, J.W. (2002). Molecular cloning and characterization of CAPER, a novel coactivator of activating protein-1 and estrogen receptors. J. Biol. Chem. 277, 1229-1234. https://doi.org/10.1074/jbc.M110417200
- Kang, Y.K., Putluri, N., Maity, S., Tsimelzon, A., Ilkayeva, O., Mo, Q., Lonard, D., Michailidis, G., Sreekumar, A., Newgard, C.B., et al. (2015). CAPER is vital for energy and redox homeostasis by integrating glucose-induced mitochondrial functions via ERR-alpha-Gabpa and stress-induced adaptive responses via NF-kappaB-cMYC. PLoS Genet. 11, e1005116. https://doi.org/10.1371/journal.pgen.1005116
- Klinge, C.M., Bowers, J.L., Kulakosky, P.C., Kamboj, K.K., and Swanson, H.I. (1999). The aryl hydrocarbon receptor (AHR)/AHR nuclear translocator (ARNT) heterodimer interacts with naturally occurring estrogen response elements. Mol. Cell. Endocrinol. 157, 105-119. https://doi.org/10.1016/S0303-7207(99)00165-3
- Kobayashi, A., Numayama-Tsuruta, K., Sogawa, K., and Fujii-Kuriyama, Y. (1997). CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). J. Biochem. 122, 703-710. https://doi.org/10.1093/oxfordjournals.jbchem.a021812
- Kronke, J., Udeshi, N.D., Narla, A., Grauman, P., Hurst, S.N., McConkey, M., Svinkina, T., Heckl, D., Comer, E., Li, X., et al. (2014). Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301-305. https://doi.org/10.1126/science.1244851
- Lee, J. and Zhou, P. (2007). DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol. Cell 26, 775-780. https://doi.org/10.1016/j.molcel.2007.06.001
- Mai, S., Qu, X., Li, P., Ma, Q., Cao, C., and Liu, X. (2016). Global regulation of alternative RNA splicing by the SR-rich protein RBM39. Biochim. Biophys. Acta 1859, 1014-1024. https://doi.org/10.1016/j.bbagrm.2016.06.007
- Maltepe, E., Schmidt, J.V., Baunoch, D., Bradfield, C.A., and Simon, M.C. (1997). Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386, 403-407. https://doi.org/10.1038/386403a0
- Mandl, M. and Depping, R. (2017). ARNT is a potential direct HIF-1 target gene in human Hep3B hepatocellular carcinoma cells. Cancer Cell Int. 17, 77. https://doi.org/10.1186/s12935-017-0446-2
- McIntosh, B.E., Hogenesch, J.B., and Bradfield, C.A. (2010). Mammalian Per-Arnt-Sim proteins in environmental adaptation. Annu. Rev. Physiol. 72, 625-645. https://doi.org/10.1146/annurev-physiol-021909-135922
- Owa, T., Yoshino, H., Okauchi, T., Yoshimatsu, K., Ozawa, Y., Sugi, N.H., Nagasu, T., Koyanagi, N., and Kitoh, K. (1999). Discovery of novel antitumor sulfonamides targeting G1 phase of the cell cycle. J. Med. Chem. 42, 3789-3799. https://doi.org/10.1021/jm9902638
- Reisz-Porszasz, S., Probst, M.R., Fukunaga, B.N., and Hankinson, O. (1994). Identification of functional domains of the aryl hydrocarbon receptor nuclear translocator protein (ARNT). Mol. Cell. Biol. 14, 6075-6086. https://doi.org/10.1128/MCB.14.9.6075
- Rezvani, H.R., Ali, N., Nissen, L.J., Harfouche, G., de Verneuil, H., Taieb, A., and Mazurier, F. (2011). HIF-1alpha in epidermis: oxygen sensing, cutaneous angiogenesis, cancer, and non-cancer disorders. J. Invest. Dermatol. 131, 1793-1805. https://doi.org/10.1038/jid.2011.141
- Scheuermann, T.H., Yang, J., Zhang, L., Gardner, K.H., and Bruick, R.K. (2007). Hypoxia-inducible factors Per/ARNT/Sim domains: structure and function. Methods Enzymol. 435, 3-24. https://doi.org/10.1016/S0076-6879(07)35001-5
- Semenza, G.L. (2003). Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732. https://doi.org/10.1038/nrc1187
- Sogawa, K., Nakano, R., Kobayashi, A., Kikuchi, Y., Ohe, N., Matsushita, N., and Fujii-Kuriyama, Y. (1995). Possible function of Ah receptor nuclear translocator (Arnt) homodimer in transcriptional regulation. Proc. Natl. Acad. Sci. U. S. A. 92, 1936-1940. https://doi.org/10.1073/pnas.92.6.1936
- Ting, T.C., Goralski, M., Klein, K., Wang, B., Kim, J., Xie, Y., and Nijhawan, D. (2019). Aryl sulfonamides degrade RBM39 and RBM23 by recruitment to CRL4-DCAF15. Cell Rep. 29, 1499-1510.e6. https://doi.org/10.1016/j.celrep.2019.09.079
- Uehara, T., Minoshima, Y., Sagane, K., Sugi, N.H., Mitsuhashi, K.O., Yamamoto, N., Kamiyama, H., Takahashi, K., Kotake, Y., Uesugi, M., et al. (2017). Selective degradation of splicing factor CAPERalpha by anticancer sulfonamides. Nat. Chem. Biol. 13, 675-680. https://doi.org/10.1038/nchembio.2363
- Van Kesteren, C., Beijnen, J.H., and Schellens, J.H. (2002). E7070: a novel synthetic sulfonamide targeting the cell cycle progression for the treatment of cancer. Anticancer Drugs 13, 989-997. https://doi.org/10.1097/00001813-200211000-00002
- Vorrink, S.U. and Domann, F.E. (2014). Regulatory crosstalk and interference between the xenobiotic and hypoxia sensing pathways at the AhR-ARNT-HIF1alpha signaling node. Chem. Biol. Interact. 218, 82-88. https://doi.org/10.1016/j.cbi.2014.05.001
- Wang, E., Lu, S.X., Pastore, A., Chen, X., Imig, J., Chun-Wei Lee, S., Hockemeyer, K., Ghebrechristos, Y.E., Yoshimi, A., Inoue, D., et al. (2019). Targeting an RNA-binding protein network in acute myeloid leukemia. Cancer Cell 35, 369-384.e7. https://doi.org/10.1016/j.ccell.2019.01.010
- Weir, L., Robertson, D., Leigh, I.M., Vass, J.K., and Panteleyev, A.A. (2011). Hypoxia-mediated control of HIF/ARNT machinery in epidermal keratinocytes. Biochim. Biophys. Acta 1813, 60-72. https://doi.org/10.1016/j.bbamcr.2010.11.014
- Wolff, M., Jelkmann, W., Dunst, J., and Depping, R. (2013). The Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT/HIF-1beta) is influenced by hypoxia and hypoxia-mimetics. Cell. Physiol. Biochem. 32, 849-858. https://doi.org/10.1159/000354487
- Wood, S.M., Gleadle, J.M., Pugh, C.W., Hankinson, O., and Ratcliffe, P.J. (1996). The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells. J. Biol. Chem. 271, 15117-15123. https://doi.org/10.1074/jbc.271.25.15117
- Zhu, Y.X., Braggio, E., Shi, C.X., Kortuem, K.M., Bruins, L.A., Schmidt, J.E., Chang, X.B., Langlais, P., Luo, M., Jedlowski, P., et al. (2014). Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma. Blood 124, 536-545.